Consensus development meeting 1995: combined oral contraceptives and cardiovascular disease. The Consensus Statement issued after the Second European Conference on Sex Steroids and Metabolism, Amsterdam, November 1995

Abstract

The Writing Committee far the Second European Conference on Sex Steroids and Metabolism

Committee members and members of the expert panels are listed at the end of the Consensus Statement

INTRODUCTION

The First European Conference on Sex Steroids and Metabolism took place in Esbjerg, Denmark on 18-20 May 1989. The First Conference discussed topics in epidemiology, carbohydrate and lipid metabolism and hemostasis in relation to cardiovascular diseases in women using combined oral contraceptives. Epidemiological data indicate an association between oral contraceptive use and the development of cardiovascular diseases. Plasma lipids, carbohydrate metabolism and components of hemostasis are influenced by female sex steroids, as indicated by changes during pregnancy and the menstrual cycle and differences between eugonadal and hypogonadal women of comparable age.

Key Words:

• Key words
• Combined Oral Contraceptives
• Cardiovascular Disease